Display options
Cite
Hartmann CB, Harrison MT, McCoy KL. Immunotoxicity of gallium arsenide on antigen presentation: comparative study of intratracheal and intraperitoneal exposure routes. J Immunotoxicol. 2005;2(1):1-9doi: 10.1080/15476910590930083.
Hartmann, C. B., Harrison, M. T., & McCoy, K. L. (2005). Immunotoxicity of gallium arsenide on antigen presentation: comparative study of intratracheal and intraperitoneal exposure routes. Journal of immunotoxicology, 2(1), 1-9. https://doi.org/10.1080/15476910590930083
Hartmann, Constance B, et al. "Immunotoxicity of gallium arsenide on antigen presentation: comparative study of intratracheal and intraperitoneal exposure routes." Journal of immunotoxicology vol. 2,1 (2005): 1-9. doi: https://doi.org/10.1080/15476910590930083
Hartmann CB, Harrison MT, McCoy KL. Immunotoxicity of gallium arsenide on antigen presentation: comparative study of intratracheal and intraperitoneal exposure routes. J Immunotoxicol. 2005 Jan 01;2(1):1-9. doi: 10.1080/15476910590930083. PMID: 18958654.
Copy Download .nbib Format: NLM
Share it on

J Immunotoxicol. 2005 Jan 01;2(1):1-9. doi: 10.1080/15476910590930083.

Immunotoxicity of gallium arsenide on antigen presentation: comparative study of intratracheal and intraperitoneal exposure routes.

Journal of immunotoxicology

Constance B Hartmann, M Travis Harrison, Kathleen L McCoy

Affiliations

  1. Department of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA.

PMID: 18958654 DOI: 10.1080/15476910590930083

Abstract

Gallium arsenide (GaAs) is a semiconductor utilized in electronics and computer industries. GaAs exposure of animals causes local inflammation and systemic immune suppression. Mice were administered 2 to 200 mg/kg GaAs. On day 5, intratracheal instillation increased lung weights in a dose-dependent manner and induced pulmonary inflammation exemplified by mononuclear cell infiltration and mild epithelial hyperplasia. No fibrosis, pneumocyte hyperplasia, proteinosis, or bronchial epithelial damage was observed in the lungs. Splenic cellularity and composition were unaffected. GaAs' effect on antigen presentation by macrophages was similar after intratracheal and intraperitoneal exposure, although the lowest observable adverse effect levels differed. Macrophages from the exposure site displayed an enhanced ability to activate an antigen-specific CD4(+) helper T-cell hybridoma compared with vehicle controls, whereas splenic macrophages were defective in this function. The chemical's impact on peritoneal macrophages depended on the exposure route. GaAs exposure augmented thiol cathepsins B and L activities in macrophages from the exposure site, but decreased proteolytic activities in splenic macrophages. Alveolar macrophages had increased expression of major histocompatibility complex (MHC) Class II molecules, whereas MHC Class II expression on splenic and peritoneal macrophages was unaffected. Modified thiol cathepsin activities statistically correlated with altered efficiency of antigen presentation, whereas MHC Class II expression did not. Our study is the first one to examine the functional capability of alveolar macrophages after intratracheal GaAs instillation. Therefore, thiol cathepsins may be potential target molecules by which GaAs exposure modulates antigen presentation.

Publication Types